Advances in Ocular Drug Delivery
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Mutasem Rawas-Qalaji PhD*a & Cheryl-Ann Williams MS, MBAaa College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USACorrespondence: Dr. Mutasem Rawas-Qalaji, College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328. Tel: (954) 262–1350. Fax: (954) 262–2278. E-mail: mr1250@nova.eduEye drops have long been the primary ocular drug delivery dosage form used to treat ocular disorders ranging from superficial conditions to intravitreal diseases. The ocular anatomical structure and physiological protective mechanisms are one of the most formidable barriers to drug penetration that have significantly reduced the drug’s efficacy and target selectivity while sometimes causing ocular tissue damage. There are many new and innovative advances in ocular drug delivery due to better understanding of the structure and function of the eye, the nature of its diseases, and how to overcome or utilize its protective barrier(s), which resulted in increased bioavailability and longer duration of action of the administered drugs, therefore, more effective disease management. We seek in this article to present a comprehensive overview of the basic required knowledge about the barriers for drug delivery to the eye and the major breakthroughs and advances in ocular drug delivery to the anterior, posterior and intravitreal segments of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Cited by
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
Ocular Drug Delivery: a Comprehensive Review
Ahmed, S., Amin, M. M., & Sayed, S. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02516-9 · Cited by 352
Treatment of ocular disorders by gene therapy
Solinís, M. Á., del Pozo-Rodríguez, A., Apaolaza, P. S., & Rodríguez-Gascón, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.022 · Cited by 88
Ophthalmic drug delivery using iontophoresis: recent clinical applications
Perez, V. L., Wirostko, B., Korenfeld, M., From, S., & Raizman, M. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0034 · Cited by 59
Nanoparticulate drug delivery to the retina
Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00224 · Cited by 59
Metadata
- Authors
- Rawas-Qalaji, M., & Williams, C.-A.
- Venue
- Current Eye Research
- Publisher
- Informa UK Limited
- Published
- 2012-04-17
- Volume
- 37
- Issue
- 5
- Pages
- 345-356
- ISSN
- 0271-3683 (ISSN-L)
- 1460-2202
- OpenAlex
- W2103685035
- Cited by
- 89
- References
- 1
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in Ocular Drug Delivery. https://app.cochat.ai/papers/10.3109/02713683.2011.652286
- The paper
- Rawas-Qalaji, M., & Williams, C.-A. (2012). Advances in Ocular Drug Delivery. Current Eye Research. https://doi.org/10.3109/02713683.2011.652286
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.